Navelbine and Capecitabine in the Treatment of Metastatic Breast Cancer
Clinical trial NCT00153907 · COMPLETED
Trial details
- NCT number
- NCT00153907
- Sponsor
- Dana-Farber Cancer Institute
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2002-03-01
- Primary completion
- 2011-09-01
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.